Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of rHu-EPO-Alpha in Anemia of Chronic Renal Failure
NCT00399269Phase 3Completed
- Sponsor
- Cadila Pharmaceuticals
- Start
- Dec 2006
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia of chronic kidney disease, sponsored by Cadila Pharmaceuticals. Started Dec 2006; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00399269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399269.